Amphastar Pharmaceuticals, Inc. (AMPH) vs Damora Therapeutics, Inc. (DMRA)
A side-by-side comparison of Amphastar Pharmaceuticals, Inc. and Damora Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AMPH
Amphastar Pharmaceuticals, Inc.
$25.37HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
DMRA
Damora Therapeutics, Inc.
$20.22HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — AMPH vs DMRA
growth of $100 · dividends reinvested · last 6yAMPH +25.0% (+3.8%/yr)DMRA -94.6% (-38.5%/yr)AMPH compounded faster over this window
Log scale — wide-divergence pair
AMPH DMRA
AMPH vs DMRA: by the numbers
- •DMRA is the larger company ($1.24B vs $1.12B market cap).
- •AMPH is profitable (10.76% net margin) while DMRA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | AMPH | DMRA |
|---|---|---|
| P/E ratio | 15.01 | N/A |
| Forward P/E | 8.54 | N/A |
| PEG ratio | 0.11 | N/A |
| P/S ratio | 1.53 | N/A |
| P/B ratio | 1.46 | 3.22 |
| EV / EBITDA | 8.82 | N/A |
| FCF yield | 13.67% | N/A |
Profitability
| Metric | AMPH | DMRA |
|---|---|---|
| Gross margin | 47.68% | 0.00% |
| Operating margin | 15.66% | 0.00% |
| Net margin | 10.76% | 0.00% |
| ROE | 10.23% | -50.93% |
| ROIC | 5.93% | -52.44% |
Growth (annualized)
| Metric | AMPH | DMRA |
|---|---|---|
| Revenue CAGR (5Y) | 13.71% | N/A |
| EPS CAGR (5Y) | 134.23% | N/A |
| FCF CAGR (5Y) | 23.90% | N/A |
| Total return CAGR (5Y) | 6.13% | -25.05% |
Frequently asked
- Is AMPH or DMRA more profitable?
- AMPH runs the higher net margin — AMPH at 10.76% versus DMRA at 0.00%.
- How have AMPH and DMRA total returns compared?
- Over the past 5 years, AMPH delivered 6.13% and DMRA delivered -25.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amphastar Pharmaceuticals P/E ratioAmphastar Pharmaceuticals ROEDamora Therapeutics ROEAmphastar Pharmaceuticals operating marginDamora Therapeutics operating marginAmphastar Pharmaceuticals revenue growthDamora Therapeutics revenue growthAmphastar Pharmaceuticals free cash flowDamora Therapeutics free cash flow
Amphastar Pharmaceuticals & Damora Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.